2024-07-1911316.18 KB9页5
2024-07-2011342.77 MB30页10
2024-07-201132.21 MB26页18
2024-07-20113332.27 KB21
2024-07-21113355.1 KB26页12
2024-07-2111339.5 KB2页29
2024-07-21113362.41 KB6页27
DISEASEMANAGEMENTeNSDrugs1997Feb:7(2),98-1101172-7047/97/=2-OO98/$06H)/0©AdisInternationalLimitedAllrightsreservedTrigeminalNeuralgiaAGuidetoDrugChoiceWilliamP.CheshireDepartmentofNeurology,MayoClinicJacksonville,Jacksonville,Florida,USAContentsSummary..,..,981-ClinicalFeatures,,992.DifferentialDiagnosis.993.RationaleforDrugTherapy1003.1Carbamazepine1013.2Phenytoin,...1023.3Baclofen.1023.4Sodi... 2024-07-211132.04 MB13页25
2024-07-211132.03 MB1页29
说明:“xxx万”,白细胞“又x又/msrn”,只写作“x1.本刊从18年第9143卷第期起,3对常用的计量xx”,血压单位“mmHg”也可省略,心率、脉单位,不用中文名称,改用单位符号。对一些不常用搏、呼吸只写“xx次”。的专门名称,、于3.医学上还有一些专用单位符号,目前仍暂沿用在文章中第一次出现时用中文名称,中文名称后用括号括上名称符号,文中再次出现时即传统的中文名称。为主单位,“毫克,为辅。用名称符号。4.中药处方以“克”2一为了... 2024-07-2111369.35 KB1页12
2024-07-21113747.29 KB2页9
2024-07-211133.32 MB6页25
2024-07-211131.6 MB3页27
EuropeanJournalofHeartFailure(2023)POSITIONPAPERdoi:10.1002/ejhf.2874Worseningofchronicheartfailure:definition,epidemiology,managementandprevention.AclinicalconsensusstatementbytheHeartFailureAssociationoftheEuropeanSocietyofCardiologyMarcoMetra1,#,DanielaTomasoni1,#,MariannaAdamo1,AntoniBayes-Genis2,GerasimosFilippatos3,MagdyAbdelhamid4,StamatisAdamopoulos5,StefanD.Anker6,LauraAntohi7,8,Michae... 2024-07-21113484.94 KB16页3
2024-07-221131.22 MB28页27
2024-07-25113960.34 KB59页4
2024-07-261133.04 MB35页1
2024-08-1211313.08 KB9页2
2024-08-161133.71 MB20页1
2024-07-171121.54 MB143页10